+12.0%
GSK vs TLN
-8.6%
+20.6%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TLN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | -0.5% | -0.1% | -0.6% |
| 7D | +5.2% | +1.1% | +4.1% | +5.3% |
| 30D | +10.2% | -4.6% | +14.8% | +10.0% |
| 3M | -0.9% | +5.2% | -6.1% | -0.3% |
| 6M | +3.5% | -6.5% | +10.0% | +3.8% |
| YTD | +7.2% | -3.6% | +10.9% | +8.0% |
| 1Y | +12.0% | -8.2% | +20.2% | +12.1% |
| All | +12.0% | -8.6% | +20.6% | +12.1% |
Cumulative growth
Daily Returns
Daily percentage return beside TLN.
Daily Out/Under-Performance
Portfolio return minus TLN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TLN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TLN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling